25 June 2026, Thursday
24 June 2026, Wednesday
25 June 2026, Thursday
26 June 2026, Friday
27 June 2026, Saturday
- TIME TABLE
- BOSPHORUS HALL
- TOPKAPI HALL
- GALATA HALL
- TAKSİM HALL
- KADIKÖY HALL
- STONE Amphitheatre
- A1 ROOM
- A2 ROOM
- A3 ROOM
- SULTANS ROOM
- BEBEK POSTER HALL
- MODA POSTER HALL
- BEŞİKTAŞ POSTER HALL
| 25 June 2026, Thursday | ||||||||||||||
| BOSPHORUS HALL | TOPKAPI HALL | GALATA HALL | TAKSİM HALL | KADIKÖY HALL | STONE Amphitheatre | A1 ROOM | A2 ROOM | A3 ROOM | SULTANS ROOM | BEBEK POSTER HALL | MODA POSTER HALL | BEŞİKTAŞ POSTER HALL | ||
| 07:00-08:00 | EPC – Council Meeting | 07:00-08:00 | ||||||||||||
| 08:00-08:30 | Börek with the Professors | 08:00-08:30 | ||||||||||||
| 08:30-08:55 | Opening Ceremony | 08:30-08:55 | ||||||||||||
| 08:55-10:15 | Hot Topics in Pancreatology & IAP Lifetime Achievement Award | STELLACU – CONSORTIUM | 08:55-10:15 | |||||||||||
| 10:15-10:45 | Satellite Symposium | COFFEE BREAK & SPONSORS EXHIBITION | 10:15-10:45 | |||||||||||
| 10:45-12:00 | Pancreatic Cancer – Update 2026 | Best Abstracts – Acute Pancreatitis |
Best Abstracts Varia-I | STELLACU – CONSORTIUM | 10:45-12:00 | |||||||||
| 12:00-13:00 | Satellite Symposium | 12:00-13:00 | ||||||||||||
| 13:00-14:00 | LUNCH BREAK & POSTER ROUNDS & SPONSORS EXHIBITION | SBG Meeting | LUNCH BREAK & POSTER ROUNDS & SPONSORS EXHIBITION | 13:00-14:00 | ||||||||||
| 14:00-15:00 | Hot Topics in PanNET Treatment | Best Abstracts – Chronic Pancreatitis |
EPC/IAP Acute Pancreatitis Study Group Meeting | STELLACU – CONSORTIUM | 14:00-15:00 | |||||||||
| 15:00-15:45 | Best Abstracts – Pancreatic Cancer |
15:00-15:45 | ||||||||||||
| 15:45-16:15 | Satellite Symposium | COFFEE BREAK & SPONSORS EXHIBITION | EPC & KPBA | COFFEE BREAK & SPONSORS EXHIBITION | 15:45-16:15 | |||||||||
| 16:15-17:00 | Hot Topics in Cystic Tumors | YOUPPIE Session | STELLACU – CONSORTIUM | EPC Public Affairs Committe | 16:15-17:00 | |||||||||
| 17:00-18:00 | 17:00-18:00 | |||||||||||||
| 18:00-18:30 | EPC QoC and Guidelines Committee | 18:00-18:30 | ||||||||||||
| 18:30- 19:30 | EPC Research Committe Meeting | 18:30-19:30 | ||||||||||||
| BOSPHORUS HALL | ||
| 08.30-08.55 | Opening Ceremony | |
| 08.30-08.45 | Welcome by the Presidents | Güralp O. Ceyhan (Istanbul, Türkiye), Vinciane Rebours (Paris, France) |
| 08.45-08.55 | Introduction to Acıbadem University & ASG | Ahmet Şahin (Rector of the ACU) (Istanbul, Türkiye) |
| 08.55-09.15 | IAP – Lifetime Achievement Awardee Lecture |
Chair: Kyoichi Takaori (Kyoto, Japan) |
| Targeting CD19+ B-Cells in Type 1 AIP: Reducing Flares and Supporting Steroid-Free Remission | Matthias Löhr (Stockholm, Sweden) | |
| 09.15-10.15 | Hot Topics in Pancreatology | Chairs: Patrick Michl (Heidelberg, Germany), Güralp O. Ceyhan (Istanbul, Türkiye), Kyoichi Takaori (Kyoto, Japan) |
| 09.25-09.41 | Gut-Pancreas Axis – from Microbes to Immune Cells | Albrecht Neeße (Göttingen, Germany) |
| 09.31-09.47 | From EUS Images to Risk Scores: Artificial Intelligence and Radiomics in Endoscopic Management of Pancreatic Lesions | Silvia Carrara (Milan, Italy) |
| 09.47-09.59 | Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Primary and final analysis from the Phase 3 RASolute 302 study | Christoph Springfeld (Heidelberg, Germany) |
| 09.59-10.15 | The Mistakes I Made in My Scientific Careeer | Markus Lerch (Munich, Germany) |
| 10.15-10.45 | Coffee Break | Satellite Symposium |
| 10.45-12.00 | Pancreatic Cancer – Update 2026 | Chairs: Jörg Kleeff (Halle, Germany), Daniel Öhlund (Umea, Sweden), Ashok Saluja (Miami, USA) |
| 10.45-11.00 |
When Tumors Starve the Body: Organ Wasting in Pancreatic Cancer |
Yetiş Gültekin (Cambridge, USA) |
| 11.00-11.15 | New Class of RAS Inhibitors will Change the Therapeutic Landscape in Pancreatic Cancer | Hana Algül (Munich, Germany) |
| 11.15-11.30 | The Novel Multidisciplinary Pancreatic Cancer Guidelines – What will Change? | Elena Rangelova (Gothenburg, Sweden) |
| 11.30-12.00 | Best Pancreatic Cancer Abstract | |
| 11.30-11.40 | RNA-sequencing on EUS-acquired tissue of pancreatic cancer at diagnosis and after first-line chemotherapy allows identification of biomarkers of prognosis and response to chemotherapy: first results from the PACEUT trial | Claudia Fortunato (Milan, Italy) |
| 11.40-11.50 | Predicting disease recurrence following surgical resection of adenocarcinoma arising from intraductal papillary mucinous neoplasms (A-IPMN) using a machine learning model: Results from a multicenter study | Christos Athanasiou (Newcastle ,UK) |
| 11.50-12.00 | Intratumoral nerves drive immune suppression in pancreatic ductal adenocarcinoma via the recruitment of myeloid-derived suppressor cells | Kaan Cifcibasi (Munich ,Germany) |
| 12.00-13.00 | Satellite Symposium | |
| 13.00-14.00 | Lunch | |
| 14.00-15.45 | Hot Topics PanNET – Theranostics, Surgery & Local Ablation in PanNET: How Should We Change Practice Tomorrow? | Chairs: Katherine A. Morgan (New York, USA), Anna Caterina Milanetto (Padova, Italy), Kazushige Uchida (Kochi, Japan) |
| 14.00-14.15 | Liquid Biopsies in PanNET: NETest, cfDNA and ctDNA to Guide Surveillance and Early Intervention | Roberta Elisa Rossi (Milan, Italy) |
| 14.15-14.30 | Designing the Next Generation of Adjuvant and Neoadjuvant Trials in PanNET: Learning from Advanced Disease | Katherine A. Morgan (New York, USA) |
| 14.30-14.45 | G3 PanNET versus NEC: When Does Surgery Still Make Sense? | Mert Erkan (Istanbul, Turkiye) |
| 14.45-15.00 | Surgery for Multimetastatic PanNET with Liver Metastases: How Far is Too Far? | Stefano Partelli (Milan, Italy) |
| 15.00-15.15 | Theranostics in PanNET: Optimising PRRT and Emerging Radioligand Strategies |
Louis de Mestier (Paris, France) |
| 15.15-15.30 | EUS Ablation vs Surgery for Insulinomas and Small NF-PanNETs: Complications, Long-Term Control and Quality of Life | Stefano F. Crinò (Verona, Italy) |
| 15.30-15.45 | Best PanNET Abstracts | |
| 15.30-15.39 | Prediction of pancreatic neuroendocrine tumor grading using an artificial intelligence-based video analysis model (GradAINet) applied to contrast-enhanced endoscopic ultrasound videos | Matteo Tacelli (Milano ,Italy) |
| 15.39-15.48 | Spatial and temporal intratumor heterogeneity of Pancreatic neuroendocrine tumors (PanNETs) | Zaima Afzal Awan (Clichy ,France) |
| 15.45-16.15 | Coffee Break | Satellite Symposium |
| 16.15-18-30 | Cystic Tumors of the Pancreas 2025: Precision Stratification, Molecular Profiling & Next-Generation Management | Chairs: Roberto Salvia (Verona, Italy), Djuna Cahen (Amsterdam, Netherlands) Masafumi Nakamura (Fukuoka, Japan) |
| 16.15-16.35 | What Can We Expect from the Novel Multidisciplinary Guidelines? | Djuna Cahen (Amsterdam, Netherlands) |
| Rethinking Guidelines | ||
| 16.35-16.50 | BD-IPMN: Stop or Continue Surveillance? | Masayuki Kitano (Wakayama, Japan) |
| 16.50-17.05 | Main-duct IPMN: still “Resect All”? | Giovanni Marchegiani (Padova, Italy) |
| 17.05-17.20 | MCN and SPN: Selective Surgery vs Classical Dogma | Christopher Wolfgang (New York, USA) |
| Molecular Subtypes, Risk Stratification & AI Future | ||
| 17.20-17.35 | Molecular Roadmaps of Pancreatic Cystic Neoplasms: From KRAS to Multi-Omics | Claudio Luchini (Verona, Italy) |
| 17.35-17.50 | Beyond Cyst Size: Liquid and EUS Biopsies to Predict Malignant IPMN | Dong-Wang Seo (Soeoul, South Korea) |
| 17.50-18.05 | AI for Pancreatic Cysts: Beating the Guidelines at Predicting Malignancy | Tamas Gonda (New York, USA) |
| 18.05-18.30 | Best Cystic Tumors Abstracts | |
| 18.05-18.14 | Downregulation of circulating miR-101 and miR-451a as Early Indicators of IPMN Progression to PDAC | Chiara Corradi (Pisa ,Italy) |
| 18.14-18.23 | The mechanism of three-dimensional proliferative progression of IPMN identified by spatial transcriptome analysis of patient-derived organoids | Masahiro Shiihara (Miyagi ,Japan) |
| 18.23-18.32 | A multi-layer perceptron model for multi-omics data integration in IPMN-to-PDAC progression and transition | Giulia Peduzzi (Pisa ,Italy) |
| TOPKAPI HALL | ||
| 10.45 – 12.00 | Best Abstracts – Acute Pancreatitis | Chairs: Dilek Oğuz (Kırıkkale, Turkiye), Robert Sutton (Liverpool, UK) |
| 10.45-10.54 | Incidence and diagnosis of disrupted pancreatic duct in acute necrotizing pancreatitis: a nationwide multicenter prospective cohort study (POLAR study) | Hannah Sopie Pauw (Nieuwegein ,The Netherlands) |
| 10.54-11.03 | Machine Learning–Based Stratification to Guide the Use of Endoscopic Ultrasound in Idiopathic Acute Pancreatitis: Prospective Validation of the Microlithiasis Prediction Score | Simon Sirtl (Munich ,Germany) |
| 11.03-11.12 | Peripheral opioid antagonism does not affect inflammatory biomarker response in Acute Pancreatitis: Insights from a multicenter, randomized, controlled trial | Amer Hadi (Hvidovre ,Denmark) |
| 11.12-11.21 | Macrophage-derived Cathepsin S links pancreatic inflammation to neuronal CREB signaling and pain | Okan Safak (München ,Germany) |
| 11.21-11.30 | Potentiation of PMCA activity by methylene blue can attenuate alcohol-induced acute pancreatitis | Zsófia Horváth (Szeged ,Hungary) |
| 11.30-11.39 | Calcium-sensing receptor inhibition alleviates acute pancreatitis by attenuating calcium overload and modulating immunity | Robert Sutton (Liverpool, UK) |
| 11.39-11.48 | Cholesterol as a determinant of pancreatic disease progression. A post-hoc analysis of prospectively collected longitudinal data | Mónika Lipp (Budapest ,Hungary) |
| 11.48-11.57 | A Bioinspired Macrophage-Cytotaxi System Targeting Pancreas and Promoting M2 Reprogramming for Mitigation of Acute Pancreatitis | Zengkan Du (Shanghai ,China) |
| 13.00-14.00 | Lunch | |
| 14.00 – 15.00 | Best Abstracts – Chronic Pancreatitis | Chairs: Murat Saruç (Istanbul, Turkiye ), Christoph Michalski (Heidelberg, Germany) |
| 14.00-14.10 | The French PRSS1 cohort: Natural history of hereditary pancreatitis – The PARADISIO-1 Study | Guillaume Cléry (Paris ,France) |
| 14.10-14.20 | The Silent Burden of Painless Chronic Pancreatitis: Insights from the ITARECIPE Prospective Registry | Gabriele Capurso (Milan ,Italy) |
| 14.20-14.30 | A Clinical Risk Score for Early Thrombosis Detection in Acute and Chronic Pancreatitis: Insights From a Large Cohort Study | Jakob Vielhauer (Munich ,Germany) |
| 14.30-14.40 | Notch Signaling and Chronic Pancreatitis | Srikanth Iyer (Iowa City ,United States) |
| 14.40-14.50 | Macrophage Piezo1 sustains pancreatic stellate cell activation via purine metabolism to promote chronic pancreatitis progression | Jie Wu (BeiJing ,China) |
| 14.50-15.00 | NMDAR1A- and IL-10-centered Neuroimmune Targeting Breaks the Pain Cycle in Chronic Pancreatitis | Nedim Can Cevik (Istanbul ,Türkiye) |
| 15.00 – 15.45 | Best Abstracts – Pancreatic Cancer | Chairs: Özlem Er (Istanbul, Turkiye), Rouzzana Giesert Istvanffy (Munich, Germany) |
| 15.00-15.09 | Reduced CFTR expression promotes pancreatic tumor progression in mice and is associated with metastasis and worse survival in human pancreatic cancer | Eva C. Vaquero (Barcelona ,Spain) |
| 15.09-15.18 | Impact of DNA Damage Rapair (DDR) genes germline pathogenic variants (gPV) in metastatic pancreatic cancer patients (pts) receiving Nab-Paclitaxel / Gemcitabine (AG) or Cisplatin, Nab-Paclitaxel, Capecitabine and Gemcitabine (PAXG) first line therapy | Guido Giordano (Foggia ,Italy) |
| 15.18-15.27 | Co-evolution of Oncogenic KRAS Signaling and LILRB-high Macrophages Drives Pancreatic Cancer Recurrence | Jianzhen Lin (Nanjing ,China) |
| 15.27-15.36 | Unraveling The Role of CXCL8 in Pancreatic Cancer-Schwann Cell Crosstalk: Mechanisms of Neuroinvasion and Therapeutic Targeting | Tayyar Emir Gözeler (İstanbul ,Türkiye) |
| 15.36-15.45 | Survival impact after resection for postoperative recurrence or metastasis of pancreatic ductal adenocarcinoma analyzed using a time-dependent cox regression model | So Yamaki (Hirakata ,Japan) |
| 15.45-16.15 | Coffee Break | |
| 16.15-18.30 | YOUPPIE SESSION The Game of Pancreas: Mastering Pancreatology from Basics to Youppie Throne |
Chairs: Lucia Guilabert (Elche, Spain), Sara Nikolić (Maribor, Slovenia) |
| 16.15-16.20 | Case Presentation | Lucia Guilabert (Elche, Spain), Sara Nikolić (Maribor, Slovenia) |
| 16.20-16.30 | Kicking Off Strong: The Initial Management of Acute Pancreatitis | Catalina Vladut (Bucharest, Romania) |
| 16.30-16.40 | Feed Me Right: Nutrition in Acute Pancreatitis | Nina Blažević (Zagreb, Croatia) |
| 16.40-17.00 | Trouble Ahead: Managing Complications Like a Pro | Giacomo Rizzo (Sicily, Italy), Thomas Hank (Heidelberg, Germany) |
| 17.00-17.10 | Life After the Storm: Post–Acute Pancreatitis Consequences | Veronika Lillik (Budapest, Hungary) |
| 17.10-17.20 | Discussion and Questions | |
| Future in Focus: Empowering Young Pancreatologists | ||
| 17.20-17.27 | Pancreas 2000 Project The BYOB study, Body Composition and Outcomes in Acute and Chronic Pancreatitis: a Pancreas2000 Multicentre Study |
Hanna Paw (Utrecht, Netherlands) |
| 17.27-17.34 | Pancreas 2000 Project The MEPAC Study: Oligometastatic Pancreatic Cancer Surgically Treated |
Roberto Montorsi (Verona, Italy) |
| 17.34-17.46 | From the Medical Crib: Shapping the Pancreatologists of Tomorrow – a JPC Success Story | Julia Straesser (Kiel, Germany) |
| EPC Fellowships | ||
| 18.01-18.06 | EPC Fellowship | Kasper Overbeek (Rotterdam, Netherlands) |
| 17.46-17.51 | EPC Fellowship Bridging the Gap from Clinical Practice to Academic Pancreatology |
Laura Gutiérrez-Rios (Barcelona, Spain) |
| YOUPPIE THRONE | ||
| 17.51-18.00 | Male Youppie Awardee The Rolling Stone in 2026 – Towards an Individualized Biliary Pancreatitis Therapy |
Simon Sirtl (Munich ,Germany) |
| 18.00-18.10 | Female Youppie Awardee The “Translational Endoscopist”: a Mythological Figure to Tackle Pancreatic Cancer |
Livia Archibugi (Milan, Italy) |
| GALATA HALL | ||
| 10.45-13.00 | Best Abstracts Varia-I | Chairs: Nevin Oruç (Izmir, Turkiye) |
| 10.45-10.54 | Loss of CFTR enhances mesenchymal traits and lysosome dysfunction in pancreatic stellate cells | Raquel Ibañez (Lleida ,Spain) |
| 10.54-11.03 | Differentiating pancreatic cancer and chronic pancreatitis: a novel MDCT postprocessing approach | Konstantin Lesko (Moscow ,Russia) |
| 11.03-11.12 | Systematic Review and Meta-analysis of Health-Related Quality of Life Outcomes after Total Pancreatectomy and Islet Auto-transplantation | Vivek Peddakota (Newcastle ,UK) |
| 11.12-11.21 | Using GWAS and AI-Based Regulatory Models to Prioritize Pancreatic Cancer Risk Variants for Functional Studies | Pelin Ünal (Antalya ,Türkiye) |
| 11.21-11.30 | A Pancreas Phantom mimicking natural pancreatic mechanical properties: bridging engineering and endoscopic ultrasound for reproducible Shear Wave Evaluation | Maria Terrin (Milan ,Italy) |
| 11.30-11.39 | Endoscopic Therapy and Laser Lithotripsy for Painful Idiopathic Chronic Pancreatitis: A Five-Year Single-Centre Experience from South India — Outcomes, Stone Clearance, and Predictors of Response | Rizwan Ahamed (Ernakulam ,India) |
| 11.39-11.48 | Whole exome sequencing identifies a genetic signature for intraductal papillary mucinous neoplasm evolution into pancreatic ductal adenocarcinoma | Sinan Saglam (Pisa ,Italy) |
| 11.48-11.57 | Multiparametric Endoscopic Ultrasound (EUS) for solid pancreatic tumors: added value of detective flow imaging (DFI) to Elastography and Contrast Enhancement (CE-EUS) | Rodrigo Montoto Meijide (Santiago de Compostela ,Spain) |
| 11.57-12.06 | Pancreas and Islet Transplantation versus Insulin Therapy in patients with Type 1 Diabetes undergoing Renal Transplantation: A Systematic Review and Meta-Analysis | Arnold Marchis (Budapest ,Hungary) |
| 12.06-12.15 | Intratumoral Microbiome Composition Differs Across Gastrointestinal Cancer Types: Insights from a Contamination-Controlled 16S Approach | Emel Comak (Tübingen ,Germany) |
| 12.15-12.24 | Modeling pressure-dependent epithelial cell responses in human pancreatic apical-out organoids | Aletta Kata Kiss (Szeged ,Hungary) |
| 12.24-12.33 | Analysis of deep neural networks in the differentiation and endosonographic diagnosis of focal lesions of the pancreas | Barbara Wlodarczyk (Lodz ,Poland) |
| 12.33-12.42 | Evaluation of genetic testing discussions and referral pathways in pancreatic cancer: adherence to NICE NG85 and the NHS Genomic Test Directory (R367) | Adil Nazir (Stoke On Trent ,United Kingdom) |
| 12.42-12.51 | Imaging biomarkers tracking chronic pancreatitis progression – a 4-year prospective multiparametric MRI study | Sigrid Bergmann (Aalborg ,Denmark) |
| 12.51-13.00 | Development of an Artificial Intelligence Model to Predict Preoperative Islet Yield During Total Pancreatectomy and Islet Autotransplantation (TPIAT) | Vivek Peddakota (Newcastle ,UK) |
| 13.00-14.00 | Lunch | |
| 14.00-15.45 | Acute Pancreatitis Study Group – EPC/IAP 2026 Session | Chair: Sanjay Pandanaboyana (Newcastle Upon Tyne, UK) |
| 14.00-14.15 | Rabi-767 Study | Timothy Gardner (New Hampshire, USA) |
| 14.15-14.30 | Insights into Mechanisms of Systemic Effects of Acute Pancreatitis from Analysis of Serum Proteins | Stephen Pandol (Los Angeles, USA) |
| 14.30-14.45 | A Global Phase 3 Trial of Auxora in Acute Pancreatitis | Robert Sutton (Liverpool, UK) |
| 14.45-15.00 | CAPPOS Project | Louise Kuhlmann (Aalborg, Denmark) |
| 15.00-15.15 | Studies from Newcastle Pancreas Study Group: SARCOPANC/OXIPANC/PANCPLEURAL studies | Sanjay Pandanaboyana (Newcastle Upon Tyne, UK) |
| 15.15-15.30 | Studies from the Dutch Pancreatitis Study Group (PLANCTON, PICUS-2) | Lars VanderBroeck (Utrecht, The Netherlands), Rolf Schwartz (Utrecht, The Netherlands) |
| 15.30-15.45 | Studies from the Hungarian Pancreatic Study Group (PANCA, PPDM, ARPAD, LIFESPAN, EFFORT, PROSECCO) | Bálint Eröss (Budapest, Hungary) |
| 15.45-16.00 | Balanced Solution Versus Normal Saline in Acute Pancreatitis: What’s Next? | Lu Ke (Shenyang, China) |
| TAKSİM HALL | ||
| 08:55-09:10 | Welcome and Strategic Framing | |
| From StellaTUM to StellACU: What the Next-Generation PSC/CAF Consensus Must Deliver | Mert Erkan (Istanbul, Turkiye) | |
| 09.10–10.15 | Session 1: PSC States, Heterogeneity and Plasticity in Pancreatic Disease | Chairs: Atsushi Masamune.(Sendai, Japan) , Stephen Pandol (Los Angeles, USA) |
| 09.10–09.25 | Origins to States: Stellate Cell Activation and Role in Pancreatitis | Minoti Apte (Sydney, Australia) |
| 09.25–09.40 | Shin Hamada (Sendai, Japan) | |
| 09.40–09.55 | CAF State Frameworks: A Minimal Taxonomy Compatible Across Studies and Technologies | Raghu Kalluri (Houston, USA) |
| 09.55–10.15 | Discussion and Outputs | |
| 10.15-10.45 | COFFEE BREAK | |
| 10.45–12.30 | Spatial Biology, ECM Architecture and CAF Function | Chairs: Bo Kong (Heidelberg, Germany), Irene Esposito (Dusseldorf, Germany) |
| 10.45-11.00 | The Role of Stroma in Early Pancreatic Carcinogenesis | Jörg Kleeff (Halle, Germany) |
| 11.00-11.15 | Stromal Architecture Through a Clinical Lens: Impact of ductal drainage on carcinogenesis and diabetes | Mert Erkan (Istanbul, Turkiye) |
| 11.15–11.30 | Neurostromal Interactions in PDAC | Ekin Demir (Munich, Germany) |
| 11.30 -11.45 | Pancreatic Cancer Related Diabetes (PCRD) : PSC-Islet Interactions in PDAC | Chamini Perera (Sydney, Australia) |
| 12.00–12.15 | CAF Heterogeneity and Immune Modulation in PDAC | Susanne Roth (Tübingen, Germany) |
| 12.15–12.30 | Wrap-up and Outputs | |
| 13.00-14.00 | LUNCH BREAK | |
| 14.00–15.45 | Session 3: Models, Technologies, Translation and Trial Design Part A: Models and Technologies | Chairs: Raghu Kalluri (Houston, USA), Hana Algül (Munich, Germany) |
| Part A: Models and Technologies | ||
| 14.00–14.10 | Organoid and Developmental PDAC Models | Matthias Hebrok (Munich, Germany) |
| 14.20–14.30 | Human-Relevant Systems and Clinical Integration | Mattias Löhr (Stockholm, Sweden) |
| 14.30–14.40 | Standardised Experimental Models to Assess CAF-Cancer interactions | Bo Kong (Heidelberg, Germany) |
| 14.40–14.50 | AI-Guided Spatial Oncology | Kıvanç Görgülü (Munich, Germany) |
| Part B: Translation and Clinical Trial Design | ||
| 14.50–15.00 | From Preclinical Endpoints to Clinical Reality: Stromal Targeting and CAF-Informed Trials | Hana Algül (Munich, Germany) |
| 15.00–15.10 | Pathology-Based Biomarkers of CAF Heterogeneity | Irene Esposito (Dusseldorf, Germany) |
| 15.20–15.30 | Emerging CAF-Directed Strategies for Rational Testing | Joo Kyung Park (Seoul, South Korea) |
| 15.30–15.45 | Wrap-up and Outputs Purpose: Quick Q&A and transition to Panel | |
| 15.45-16.15 | COFFEE BREAK | |
| 16.15–17.00 | Structured Panel: Trial Design Convergence | Chair: Helmut Friess (Munich, Germany), Güralp Ceyhan (Istanbul, Turkiye) |
| Finalised principles for CAF-informed trial design; Consensus biomarker package; Agreed trial endpoint framework |
Stephen Pandol (Los Angeles, USA), Mert Erkan (Istanbul, Turkiye), Irene Esposito (Dusseldorf, Germany), Minoti Apte (Sydney, Australia), Atsushi Masamune (Sendai, Japan), Mathias Löhr (Stockholm, Sweden) |
|
| 17.00–18.00 | Final Consensus Consolidation and Voting | |
| Voting on terminology and reporting standards Confirmation of model and functional prioritisation Agreement on trial principles Writing group formation Delphi and manuscript timeline confirmation |
||
| STONE Amphitheatre | |
| 08.00-08.30 | Börek with the Professors |
| A1 ROOM | ||
| 13.00-14.00 | SBG Meeting | |
| 15.45-16.15 | EPC & KPBA | |
| A2 ROOM | ||
| 16.15-17.00 |
EPC Public Affairs Committe |
|
| 18.00-19:30 | EPC Quality of Care and Guidelines Committee | |
| A3 ROOM | ||
| SULTANS ROOM | |
| 07.00-08.30 | EPC – Council Meeting |
Bebek Poster Hall / 13.00 – 14.00 |
|||
*Please kindly note that each presentation is allocated 4 minutes (3-minute presentation + 1-minute discussion) |
|||
| AbsRef | Pub Number | Title | Presenter |
| Group -1 | Chairs: Masayuki Kitano (Wakayama, Japan), Nuria Malats (Madrid, Spain) | ||
| 89 | PPCC-001 | Vascular resection in robotic pancreaticoduodenectomy for pancreatic cancer: a propensity score-matched study | Bor Uei Shyr |
| 90 | PPCC-002 | Impact of mesopancreas dissection level 3 in robotic pancreaticoduodenectomy for pancreatic head cancer – a propensity score-matched study | Bor Shiuan Shyr |
| 94 | PPCC-003 | Results of surgical treatment of ductal adenocarcinoma of the head of the pancreas with involvement of the main vessels and involvement of the vascular margins of resection | Andrii Savytskyi |
| 95 | PPCC-004 | Impact of Feeding Jejunostomy on Postoperative Outcomes After Whipple’s Procedure: A Comparative Propensity Score Analysis Using the Comprehensive Complication Index | Rohith Kodali |
| 105 | PPCC-005 | Förster Resonance Energy Transfer (FRET) Nanoprobe can diagnose Pancreatic Juice Activation from Postoperative Pancreatic Fistula | Satoshi Mizutani |
| 119 | PPCC-006 | Setting the Optimal Arterial Divestment Outcomes in Pancreatic Surgery | Susanna Tondato |
| 123 | PPCC-007 | Differential Diagnostic Criteria for Pancreatic Adenocarcinoma vs. Chronic Pancreatitis: A Morphological Study | Natalia M. Honcharova |
| 124 | PPCC-008 | Diagnostic Efficacy of TGF-β1 and CA 19-9 in Distinguishing Benign from Malignant Pancreatic Lesions | Natalia M. Honcharova |
| 173 | PPCC-009 | Preoperative Tooth Count Predicts Long-Term Survival After Curative Resection for Pancreatic Ductal Adenocarcinoma: A Retrospective Cohort Study | Kenichiro Uemura |
| 185 | PPCC-010 | Pattern and risk factors for postoperative recurrence in borderline resectable pancreatic cancer after upfront surgery | Han Xuan Wang |
| 186 | PPCC-011 | Intrapancreatic Fat Deposition on Pre-diagnostic Non-contrast CT Is Independently Associated with Pancreatic Ductal Adenocarcinoma | Arjun Chatterjee |
| 196 | PPCC-013 | The Impact of Body Mass Index on Predicting Postoperative Pancreatic Fistula in Relation to Pancreatic Texture and Main Pancreatic Duct Diameter After Pancreaticoduodenectomy | Kostiantyn Kopchak |
| 198 | PPCC-014 | The clinical significance of CAPRIN-1 expression in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma underwent pancreatectomy | Sang Thanh Nguyen |
| 201 | PPCC-015 | Cancer aggregation beyond the pancreas in families with familial pancreatic cancer: a population-based comparison using the Italian Registry of Families At Risk of Pancreatic Cancer data | Erica Secchettin |
| 203 | PPCC-016 | Longitudinal changes in triceps skinfold thickness and serum albumin during chemotherapy in patients with pancreatic cancer: Sex-based prognostic insights | Jongkyun Lee |
| Group – 2 | Chairs: Albrecht Neeße (Göttingen, Germany), Helmut Friess (Munich, Germany) | ||
| 210 | PPCC-017 | Impact of chemotherapy dose-intensity and protocol guidelines violations on neoadjuvant treatment outcome in pancreatic ductal adenocarcinoma | Anna Fosfuri |
| 214 | PPCC-019 | Beyond Incidence: Changing Sex Dynamics and the Expanding Population Burden of Pancreatic Cancer in Hungary | Gábor Mohácsi |
| 262 | PPCC-020 | Serum MMP-8 and TIMP-1 as prognostic factors in pancreatic ductal adenocarcinoma | Ella Kesti |
| 274 | PPCC-021 | Minimally Invasive Pancreatectomies for Pancreatic Tumors | Igor Khomiak |
| 275 | PPCC-022 | Genomic determinants of relapse and survival in early stage and metastatic pancreatic ductal adenocarcinoma | Beatrice Mohelnikova Duchonova |
| 279 | PPCC-023 | Healthcare Expenditures Across the Care Continuum of Pancreatic Cancer and Resected Precursor Lesions in the Netherlands | Djuna L. Cahen |
| 288 | PPCC-024 | Preoperative CA 19-9 and Prognosis in Resectable Pancreatic Ductal Adenocarcinoma | Rayhan Rejeb |
| 290 | PPCC-025 | High Preoperative CA 19-9 Predicts Early Recurrence and Metastatic Patterns in Pancreatic Ductal Adenocarcinoma | Rayhan Rejeb |
| 291 | PPCC-026 | Intratumoral expression of cytidine deaminase (CDA) in resected pancreatic ductal adenocarcinoma (PDAC) | Nils Oskar Elander |
| 302 | PPCC-027 | Age-adjusted Charlson Comorbidity Index (ACCI) Predicts Adjuvant Therapy after Resection for Pancreatic Ductal Adenocarcinoma | Kira Meißner |
| 309 | PPCC-028 | Preoperative CA 19-9 as a Predictor of Surgical Margin Status and Survival in Resectable Pancreatic Ductal Adenocarcinoma | Rayhan Rejeb |
| 310 | PPCC-029 | Impact of Postoperative Complications on Survival in Resectable Pancreatic Ductal Adenocarcinoma | Rayhan Rejeb |
| 316 | PPCC-030 | Body surface gastric mapping to determine patterns of gastric electrical activity associated with delayed gastric emptying after pancreaticoduodenectomy | Sanjay Pandanaboyana |
| 317 | PPCC-031 | Tumor budding assessment in pancreatic carcinoma: automated evaluation using digital pathology in a low-resource setting | Myriam Ayari |
| 355 | PPCC-034 | Apolipoprotein A2 isoforms as blood biomarkers reflecting pancreatic exocrine function: clinical implications for IPMN and post-pancreatectomy steatotic liver disease | Kazufumi Honda |
| Group – 3 | Chairs: Takao Ohtsuka (Kagoshima, Japan), Başak Oyun Uluç (Istanbul, Turkiye) | ||
| 363 | PPCC-035 | Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma with Liver Metastasis: A Nationwide Multicancer Study | Daisuke Hashimoto |
| 390 | PPCC-036 | Gut microbiota differentiates chronic pancreatitis from pancreatic ductal adenocarcinoma and indicates alterations in short chain-fatty acid metabolism | Jacob Hamm |
| 395 | PPCC-037 | The method “Arterial resection (AR) and reconstruction before mobilization of the pancreas” (ARRBMP) for locally advanced pancreatic cancers (LAPDAC) surgery. Results of 183 arterial segments resections in 121 patients | Viacheslav Egorov |
| 399 | PPCC-038 | Three types of arterial anatomy after spleen-preserving distal pancreatectomies (SPDP) with splenic vessels resection(SVR). How to use this knowledge for organs’ preservation in treatment of locally advanced pancreatic head cancers (LAPHC) | Viacheslav Egorov |
| 400 | PPCC-039 | The rise of pancreatic cancer mortality in Italy: a call for urgent healthcare action. Ten-year National and regional forecasts until 2035 | Samuele Grandi |
| 406 | PPCC-040 | Prognostic immune nutritional index is a valuable prognostic marker in advanced pancreatic cancer | Mariia Kiriukova |
| 416 | PPCC-041 | Tumor response scoring systems for pancreatic ductal adenocarcinoma: Systematic Review and Meta-analysis | Roberta Vella |
| 417 | PPCC-042 | Optimization of treatment strategies for patients with borderline resectable and locally advanced pancreatic cancer | Liudmyla Pererva |
| 420 | PPCC-043 | Comparing pre-treatment systemic inflammation and sarcopenia in pancreatic cancer | Myriam Ayari |
| 427 | PPCC-044 | Who achieves long-term survival after pancreatoduodenectomy for pancreatic cancer? A single-center analysis of prognostic factors | Pavel Skalicky |
| 430 | PPCC-045 | Prevention strategies and treatment of postoperative complications after pancreatoduodenectomy | Volodymyr Kopchak |
| 433 | PPCC-046 | Uncovering the hidden fat: myosteatosis as a novel prognostic marker in pancreatic adenocarcinoma | Myriam Ayari |
| 444 | PPCC-047 | From Radiological to Biological Resectability: A Prognostic Shift via cfDNA Fragmentomics in Pancreatic Cancer | Lingdi Yin |
| 446 | PPCC-048 | Postoperative and survival implications of standard and extended surgery compared to non-resectional procedures for localized pancreatic ductal adenocarcinoma | Fabio Casciani |
| 450 | PPCC-049 | Nine-year temporal treatment trends and prognostic factors of survival after resection for pancreatic malignant epithelial tumors: a 3,137-case single-center retrospective study | Kuirong Jiang |
| Group – 4 | Chairs: Patrick Michl (Heidelberg, Germany), Lena Seifert (Dresden, Germany) | ||
| 452 | PPCC-050 | Pancreatic Cancer in the Uncinate Process with Vascular Involvement: An International Multicenter Study of Surgical and Oncological Outcomes after Neoadjuvant Therapy | Hiroyuki Ishida |
| 473 | PPCC-051 | Circulating tumor DNA in pancreatic cancer: time to adopt in clinical pratice | Filipe Castro Borges |
| 481 | PPCC-052 | Radicality in pancreatoduodenectomy: where the east meets the west | Inês Faria Teixeira |
| 492 | PPCC-053 | Pancreatic Cancer Derived Organoids Allow Personalised Drug Screening | Wei Liu |
| 493 | PPCC-054 | Neoadjuvant Chemotherapy Versus Upfront Surgery for Pancreatic Ductal Adenocarcinoma with CT-Suspected Vascular Invasion: Association with Overall Survival and Microvascular Invasion Response | Jianzhen Lin |
| 495 | PPCC-055 | Prognostic Value of Lymph Node Ratio After Curative Resection for Pancreatic Ductal Adenocarcinoma | Manel Yakoubi |
| 501 | PPCC-056 | A Rare Case: Primary Pancreatic Lymphoma | İsmail Atasoy |
| 502 | PPCC-057 | Pancreatic juice lipidomic profiling for prognostic stratification in pancreatic ductal adenocarcinoma | Elena Desiato |
| 508 | PPCC-058 | Metastasis-directed ablative treatment in addition to systemic chemotherapy in oligometastatic pancreatic ductal adenocarcinoma: A systematic review and meta-analysis | Melinda Piri |
| 525 | PPCC-059 | Socioeconomic Deprivation Adversely Affects the Routes to Diagnosis and Long-term Outcomes in Patients with Pancreatic Ductal Adenocarcinoma | Vivek Peddakota |
| 544 | PPCC-060 | Cardiovascular Risk in Pancreatic Cancer: A Meta-analysis of 197 Studies | Jázmin Németh |
| 557 | PPCC-061 | Neoadjuvant Therapy Fails to Improve Survival Compared with Upfront Surgery in Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials | Tamás Tölgyes |
| 561 | PPCC-062 | Negative prognostic implication of HER2 expression in the first-line chemotherapy for advanced pancreatic cancer | Shih Hung Yang |
| 569 | PPCC-063 | IRE-centered MDT enabled long-term survival and renewed benefit after repeat IRE in unresectable locally advanced pancreatic cancer: a case report | Yingjie Wang |
| 571 | PPCC-064 | Hemoglobin A1c Levels and the Risk of Pancreatic Ductal Adenocarcinoma. A Systematic Review and Meta-analysis | Zsófia Román |
| Group – 16 | Chairs: Viktória Venglovecz (Szeged, Hungary), Dilara Turan (Ankara, Turkiye) | ||
| 103 | PCPC-001 | Spectrum and Determinants of Acute and Chronic Pancreatitis in Choledochal Cysts | Zeeshan Ahmed |
| 128 | PCPC-002 | Paraduodenal Pancreatitis Complicated by Intramural Duodenal Hematoma and Gastrointestinal Hemorrhage | Tuğba Tolu Bülte |
| 149 | PCPC-003 | Red ginseng supplements improve quality of life in patients with mild chronic pancreatitis symptom | Jikon Ryu |
| 155 | PCPC-004 | Autoimmune pancreatitis associated with IgG4-related disease relapses more often than expected, what are their risk factors? Evidence from a large french cohort | Clémence Descourvières |
| 192 | PCPC-005 | A subgroup of chronic pancreatitis patients exhibits a hyperinflammatory phenotype characterized by upregulated IL-6/IL-17 axis signalling | Rasmus Hagn Meincke |
| 209 | PCPC-006 | Pancreatic quantitative sensory testing for pain assessment in Indian patients with chronic pancreatitis | Misbah Unnisa |
| 216 | PCPC-007 | Complete longitudinal dissection of the Wirsung’s duct and its mouth with the formation of an isolated pancreatodigestive anastomosis in patients with chronic pancreatitis with pancreatic ductal hypertension | Andrii Klymenko |
| 218 | PCPC-008 | Multimodal management of hemosuccus pancreaticus secondary to chronic pancreatitis: A 10-year single-center experience | Vladyslav Shatalo |
| 232 | PCPC-009 | Adenosquamous carcinoma complicating chronic calcifying pancreatitis: a case report | Manel Yakoubi |
| 253 | PCPC-010 | Prevalence and risk factors for malnutrition and sarcopenia in chronic pancreatitis | Samanvith Patlori |
| 285 | PCPC-011 | Long-term efficacy of a modified non-flared fully covered metal stent for refractory main pancreatic duct stricture in chronic pancreatitis: Result of a 6-year follow-up study | Jong Ho Moon |
| 295 | PCPC-012 | Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using PET/CT features: a systematic review and updated meta-analysis | Sung Hoon Moon |
| 311 | PCPC-013 | Autoimmune Pancreatitis Associated with IgG4-Related Disease: A Case Series of Four Patients | Rayhan Rejeb |
| 326 | PCPC-014 | Search for the ideal biomarker of autoimmune pancreatitis | Irina Savina |
| 268 | POTH-009 | A comparison of diagnostic scoring systems for type 1 autoimmune pancreatitis including the International Consensus Diagnostic Criteria (ICDC) | Tamara Vijfhuizen |
| Group -17 | Chairs: Susanne Roth (Tübingen, Germany), Kasper Overbeek (Rotterdam, Netherlands) | ||
| 335 | PCPC-015 | Genotypic and phenotypic characterization of CEL-HYB1 carriers in chronic pancreatitis | Renate Valdersnes Seierstad |
| 340 | PCPC-016 | The clinical course of hereditary pancreatitis in children with p.R122C mutation of the PRSS1 gene | Grzegorz Oracz |
| 344 | PCPC-017 | Sarcopenia in patients with chronic pancreatitis | Mila Kovacheva Slavova |
| 372 | PCPC-018 | Treatment of Chronic Pancreatitis with Benigh Common Bile Duct Stricture | Igor Khomiak |
| 376 | PCPC-019 | Preprocedural CT-Based Risk Stratification for Peroral Pancreatoscopy-Guided Lithotripsy in Pancreatic Duct Stones | Seok Ho Dong |
| 402 | PCPC-020 | Fecal pancreatic elastase-1 as a potential indicator for risk stratification of post-chronic pancreatitis diabetes mellitus: a multicenter cross-sectional study | Yuruchen Zhu |
| 407 | PCPC-021 | Pancreatico-portal venous fistula in pancreatitis: insights on clinicoradiological profile and outcomes from a large single-center cohort | Chandan Peddapulla |
| 424 | PCPC-022 | Fully covered metal stent usage in the treatment of pancreatic duct stenosis in chronic pancreatitis | Bengi Ozturk |
| 574 | PCPC-023 | Early chronic pancreatitis as a distinct stage in the pancreatitis continuum | Viktória Venglovecz |
| 578 | PCPC-024 | The multidimensional burden of chronic pancreatitis on health-related quality of life (HRQoL) | Emilija Nikolovska Trpchevska |
| 624 | PCPC-025 | Pancreatic Cancer in Chronic Pancreatic Inflammatory Diseases: Risk and Clinicopathological Characteristics | Tsukasa Ikeura |
| 679 | PCPC-026 | Disease stage–related associations of depression, anxiety, alcohol, and smoking in pancreatitis | Judit Lippai |
| 738 | PCPC-027 | Longitudinal clinical characteristics of a misfolding-causing mutation (PRSS1 p.L104P) associated hereditary pancreatitis | Balázs Csaba Németh |
| 257 | POTH-008 | A Case of Dorsal Pankreatic Agenesis | Civanmert Bayrak |
| 391 | POTH-015 | Therapeutic and Diagnostic Determinants in Autoimmune Pancreatitis: Steroid Induction Dosing and Criteria Framework Evaluation | Motaz Ashkar |
Moda Poster Hall / 13.00 – 14.00 |
|||
| *Please kindly note that each presentation is allocated 4 minutes (3-minute presentation + 1-minute discussion) | |||
| AbsRef | Pub Number | Title | Presenter |
| Group – 5 | Chairs: Hana Algül (Munich, Germany), Chiara Falcomatà (New York City, USA) | ||
| 111 | PPCE-001 | Stage-Specific Roles of PLA2G6 in Pancreatic Cancer Initiation and Progression | Zihan Chen |
| 116 | PPCE-002 | Identification of an IDO-1 inhibitor reducing growth of pancreatic ductal adenocarcinoma cells, but with little effect on surrounding stromal cells | Leon Heffinger |
| 157 | PPCE-003 | MicroRNA-mediated regulation of FXYD3 and its implications for PDAC progression | Ke Xin Yee |
| 164 | PPCE-004 | GARP Orchestrates Tumor Progression, Immune Suppression, and EMT Remodeling in Pancreatic Ductal Adenocarcinoma | Paul David |
| 165 | PPCE-005 | CD86 Orchestrates B-Cell Activation in PDAC and Provides a Novel Blood-Based Biomarker for Disease Aggressiveness | Paul David |
| 166 | PPCE-006 | Compartment-Specific Roles of CD44 in Pancreatic Cancer: Integrated Analyses of Lymph Nodes, Circulating Exosomes, and Tumor Immunogenomics | Alara Karabiber |
| 174 | PPCE-008 | CPT1A-mediated Fatty Acid Oxidation Drives A Classical Epithelial State in Pancreatic Cancer | Guangfu Wang |
| 180 | PPCE-009 | Targeting tumor-derived collagen to mitigate pancreatic cancer aggressiveness | Donatella Delle Cave |
| 213 | PPCE-010 | Blood biomarker discovery for early detection of pancreatic cancer using Proximity Extension Assay | Ayumi Kashiro |
| 234 | PPCE-011 | Identifying the appropriate organoid-based culture system for drug testing in Pancreatic Ductal Adenocacinoma | Christine Sophia Nitschke |
| 235 | PPCE-012 | Early-onset chronic pancreatitis alters the trajectory of dysplasia associated with oncogenic KRAS | Rebecca Reardon Lochbaum |
| 244 | PPCE-013 | Landscapes of Protein Posttranslational Modifications in Pancreatic Cancer | Yunfeng Shan |
| 247 | PPCE-014 | Chimeric antigen receptor macrophages(CAR-M) targeting claudin18.2 exhibit anti-tumor activity in pancreatic cancer | Qin Shang Yuan |
| 264 | PPCE-015 | 3D pancreatic cancer models reveal JAK/STAT3-, hypoxia- and OXPHOS-related pathways driving radioresistance | Julian Kapfer |
| 265 | PPCE-016 | PKMYT1 inhibition enhances radiosensitivity in pancreatic ductal adenocarcinoma | Arlett Patricia Gloria Schäfer |
| Group – 6 | Chairs: Francisco X. Real (Madrid, Spain), Rouzanna Giesert Istvánffy (Munich, Germany) | ||
| 266 | PPCE-017 | A Reciprocal IGFBP5–B4GALT5 Stromal–Tumor Axis Drives ECM Remodeling and PDAC Progression | Bolin Zhang |
| 269 | PPCE-018 | Translational analysis of the intratumoral microbiome and immune cell milieu in PDAC | Katharina Tillmanns |
| 284 | PPCE-019 | USP22 Promotes Treg Cell Infiltration and Modulates Immunotherapy Efficacy via the PIAS1/P65/CCL22 Pathway in Pancreatic Cancer | Aman Wang |
| 292 | PPCE-020 | Validation of a dual panel RNAScope assay for identification of Classical and Basal-like molecular subtypes of pancreatic adenocarcinoma | Christelle Bouchart |
| 312 | PPCE-021 | Tigecycline sensitizes pancreatic carcinoma models for TRAIL-induced apoptosis | Frank K. Braun |
| 314 | PPCE-022 | Gut microbial dysbiosis is associated with distinct immune checkpoint expression patterns on CD8⁺ T cells | Loreen Natusch Bufe |
| 322 | PPCE-023 | Investigation of FOLFIRINOX sensitivity and cellular death mechanisms in TGF-β-induced metastatic pancreatic cancer | Buse Birinci |
| 323 | PPCE-024 | Biopsy-Derived Primary Cell and Organoid Models of Borderline Resectable Pancreatic Cancer for Translational Research | Nevruz Alis |
| 330 | PPCE-025 | Metabolic Targeting in Pancreatic Cancer: Antitumor Activity of FX-11 and Benztropine in a PDAC Xenograft Model | Onur Onguncan |
| 332 | PPCE-026 | Unravelling the heterogeneity of CAFs in PDAC reveals a novel population: Lipofibroblasts | Didem Saka |
| 341 | PPCE-027 | In vivo CRISPR screening identifies immune checkpoint associated genes in pancreatic ductal adenocarcinoma | Christian Pilarsky |
| 347 | PPCE-028 | Integrating Deep Learning with Functional Assays to Identify Peripherally Restricted GluN2D Inhibitors Targeting Neural Invasion in Pancreatic Cancer | Esra Nalbat |
| 352 | PPCE-029 | Exosomal RNAs derived from plasma reveal PRKAG2 mRNA as a potential biomarker for pancreatic cancer in diabetic patients | Helen Binang |
| 356 | PPCE-030 | Presence and functional interaction of mesenchymal stromal cells in early pancreatic carcinogenesis | Tina Seidel |
| 357 | PPCE-031 | Influence of fibroblast activation on early pancreatic carcinogenesis | Mira Pasemann |
| Group – 7 | Chairs: Jörg Kleeff (Halle, Germany), William L. Hwang (Boston, USA) | ||
| 358 | PPCE-032 | Bile acids enhance tumorigenic properties in pancreatic ductal adenocarcinoma via TRPV6 upregulation | Boshra Yosef |
| 365 | PPCE-033 | Deciphering the Peripheral Immune Landscape in Pancreatic Cancer: Comparative Analysis and Prognostic Biomarker Discovery Using Single-Cell RNA-Sequencing | Lingdi Yin |
| 369 | PPCE-034 | Targeting IRE1α in PDAC: Therapeutic Vulnerability and Prognostic Stratification | Tamal Sarkar |
| 378 | PPCE-035 | Nano-drill-Mediated ECM Remodeling Amplifies Ferroptosis for Cancer Therapy | Zengkan Du |
| 392 | PPCE-036 | Lunapark and its role in endoplasmic reticulum stress and perineural invasion in pancreatic ductal adenocarcinoma | Nino Javakhishvili |
| 398 | PPCE-037 | Paracrine interactions and transcriptomic insights from mouse pancreatic stellate cell (PSC) spheroid co-culture with pancreatic cancer cells | Nino Javakhishvili |
| 403 | PPCE-038 | Towards a Multiscale Consensus Definition of Stromal Heterogeneity in Pancreatic ductal adenocarcinoma | Camille Pignolet |
| 409 | PPCE-040 | Aspirin alters the pancreatic stellate cell secretome to suppress tumor–nerve interactions in pancreatic cancer | Sıla Sığırlı |
| 415 | PPCE-041 | Pancreatic cancer fibrosis activates protumorigenic Schwann cells through a nuclear mechanosensing mechanism | Pavel Stupakov |
| 435 | PPCE-042 | Chimeric antigen receptor macrophages(CAR-M) targeting claudin 18.2 exhibit anti-tumor activity in pancreatic cancer | Qin Shang Yuan |
| 436 | PPCE-043 | Mapping KCMF1, PAF15 and BAG4 expression in pancreatic ductal adenocarcinoma: Associations with tumour biology and patient outcomes | Chamini Perera |
| 468 | PPCE-045 | Natural killer cell cytotoxicity decreased by tumor-associated Schwann cells against pancreatic cancer cells in vitro | Taner Kasapoglu |
| 472 | PPCE-046 | Isolation and Complex Characterisation of Pancreatic Cancer-Associated Fibroblasts from Human Cancer Tissue | Ivana Valicová |
| 477 | PPCE-047 | Functional role of very-long chain fatty acid sphingolipids in pancreatic cancer | Tahib Habshi |
| 480 | PPCE-048 | BET inhibitors as a promising therapeutic strategy for pancreatic ductal adenocarcinoma | Lucia Juhasikova |
| Group – 11 | Chairs: İhsan Ekin Demir (Munich, Germany), Bahadır Bozkırlı (Istanbul, Turkiye) | ||
| 88 | PSUR-001 | Propensity score-matched comparison of robotic and laparoscopic pancreaticoduodenectomy | Bor Shiuan Shyr |
| 91 | PSUR-002 | Predictive performance of drain amylase in Identifying Postoperative Pancreatic Fistula Following Robotic Pancreaticoduodenectomy | Bor Shiuan Shyr |
| 101 | PSUR-003 | Enzyme replacement following total pancreatectomy: population analysis | Michal Gregorik |
| 104 | PSUR-004 | Comparative efficacy of contemporary risk assessment scores in predicting risk of postoperative pancreatic fistula following distal pancreatectomy | Zeeshan Ahmed |
| 112 | PSUR-005 | Vascular outcome in pancreaticoduodenectomy with vascular resection | Bor Shiuan Shyr |
| 114 | PSUR-006 | Clinical impact of intraperitoneal drains after pancreatectomy | Philipp Palaras |
| 120 | PSUR-007 | Magnetic assisted surgical field exposure technology can shorten the operation time and improve the safety in laparoscopic distal pancreatectomy | Liang Han |
| 176 | PSUR-009 | Impact of Modified Pancreatojejunostomy Techniques on Postoperative Outcomes After Pancreatoduodenectomy | Oleksandr Kvasivka |
| 225 | PSUR-010 | Postpancreatectomy diarrhoea: prospective, single-centre longitudinal analysis of incidence, risk factors, management, and impact on quality of life | Livia Zornetta |
| 258 | PSUR-011 | Laparoscopic pancreaticoduodenectomy- initial experience in a high-volume centre | Elena Mihaela Vrabie |
| 260 | PSUR-012 | A Systematic Review of Randomised Controlled Trials on Pain Domains and Assessment Methods in Post Pancreatectomy patients | Vivek Peddakota |
| 273 | PSUR-013 | Endoscopic resection of ampullary adenomas | Igor Khomiak |
| 282 | PSUR-014 | Deep learning versus pathologist assessment of pancreatic resection margins in predicting postoperative complications after pancreatoduodenectomy | Tuija Noreila |
| 304 | PSUR-015 | Assessment of Unallocated Pancreas Grafts from Brain-Dead Donors: Implications for Expanding the Donor Pool (EXPLORE Study) | Pegah Eslami |
| 333 | PSUR-016 | Advanced age is not a risk factor for postoperative mortality after pancreatic surgery: results from a retrospective cohort analysis | Hans Michael Tautenhahn |
| Group – 12 | Chairs: Sanjay Pandanaboyana (Newcastle, UK), Ibrahim Halil Gürcinar (Munich, Germany) | ||
| 349 | PSUR-018 | Serum Interlekin-6 on POD2 and CRP on POD3 predict postoperative pancreatic fistula after pancreatoduodenectomy | Ughur Aghamaliyev |
| 366 | PSUR-019 | Safety and Efficacy of a Modified Pancreaticojejunostomy Technique in Pancreaticoduodenectomy: A Retrospective Cohort Study | Wei Liu |
| 368 | PSUR-020 | Robotic versus open pancreatoduodenectomy: an individual patient data meta-analysis of randomized trials | Julia Menso |
| 370 | PSUR-021 | Distal pancreatectomy in the era of minimally invasive pancreatic surgery; robotic vs open. Single center retrospective study | Martin Lovecek |
| 419 | PSUR-022 | Laparoscopic Subtotal Pancreatectomy: Technical Nuances and the Major Challenge of Postoperative Pancreatic Fistula – A Single-Center Experience | Sude Sezer Özkul |
| 422 | PSUR-023 | Robotic versus Open Pancreatic Surgery at a University Hospital: Early Outcomes from the Implementation of a Robotic Program | Ibrahim Halil Gurcinar |
| 425 | PSUR-024 | Analysis of clinical parameters for acquiring the learning curve sufficiency in robotic pancreaticoduodenectomy | Carolina González |
| 426 | PSUR-025 | Robotic central pancreatectomy with pancreatic anastomosis to the gastric remnant after a gastric bypass for a pancreatic neuroendocrine tumor | Carolina González |
| 438 | PSUR-026 | Minimally Invasive strategy in Pancreatic Head: Pancreaticoduodenectomy, Enucleation, or Duodenal-preserving pancreatic head resection? | Chao Lu |
| 443 | PSUR-027 | Fusion of Imaging and Clinical Features for Predicting Postoperative Pancreatic Fistula after Distal Pancreatectomy: An Explainable Machine Learning Approach | Xiaofeng Xue |
| 445 | PSUR-028 | Enhancing adjuvant chemotherapy tolerance in pancreatic adenocarcinoma following pancreaticoduodenectomy: Insights from minimally invasive surgery and home enteral nutrition | Yucheng Zhou |
| 447 | PSUR-029 | The impact of cardiac comorbidities on postoperative outcome in pancreatic head resections- a unicenter, retrospective trial | Patricia Wyzlic |
| 448 | PSUR-030 | Single vs. Double Loop Reconstruction for Pancreatic and Biliary Anastomoses in Pancreaticoduodenectomy: A Meta-Analysis of Randomized Controlled Trials | Cüneyt Kayaalp |
| 449 | PSUR-031 | High-Risk Pancreatic Anastomosis vs. Total Pancreatectomy in Pancreatoduodenectomy: A Meta-Analysis | Cüneyt Kayaalp |
| 454 | PSUR-032 | Surgical Outcomes of Pancreatoduodenectomy in Octogenarians | Cüneyt Kayaalp |
| Group – 13 | Chairs: Shailesh V. Shrikhande (Mumbai, India), Robert Grützmann (Dresden, Germany) | ||
| 496 | PSUR-033 | Postoperative day 3 serum-ascites albumin gradient may support early differentiation between biochemical leak and clinically relevant postoperative pancreatic fistula after partial pancreatic resection | Jan Bardenhagen |
| 499 | PSUR-034 | Artificial intelligence for training and quality assessment in pancreatic surgery: current evidence and future directions | Jan Bardenhagen |
| 503 | PSUR-035 | The triangle operation: 3D anatomical and histological characterisation of the vascular prism. Insights from a cadaveric study | Inês Faria Teixeira |
| 515 | PSUR-036 | Glycaemic Burden After Total Pancreatectomy | Enis Salihi |
| 529 | PSUR-037 | Biomechanical characterization of human pancreatic tissue through indentation: preliminary results for the development of artificial surgical phantom | Michele Pagnanelli |
| 539 | PSUR-038 | Superior Mesenteric Vein/Portal Vein Resection for BR/LA Pancreatic Cancer Patients after Neoadjuvant Therapy | Jingcheng Zhang |
| 710 | PSUR-039 | Inflammatory vs Non-Inflammatory Delayed Gastric Emptying After Pancreatoduodenectomy: A Distinct Clinical Phenotype Beyond ISGPS Classification | Alice Cattelani |
| 548 | PSUR-040 | Impact of Chronic Corticosteroid Therapy on Postoperative Outcomes After Pancreatic Surgery: An International Multicenter Retrospective Study | Riccardo Pellegrini |
| 558 | PSUR-041 | Pancreatic texture-specific thresholds for drain amylase and inflammatory markers to guide postoperative management after pancreatoduodenectomy | Enis Salihi |
| 565 | PSUR-042 | Ampullectomy Case for Ampullary Adenoma | Muhammed Ali Özdemir |
| 594 | PSUR-043 | MIcRobiome Analysis in patients underGoing pancrEatico-duodenectomy for pancreatic cancer (MIRAGE Study) | Claudio Ricci |
| 595 | PSUR-044 | When Survival Models Fail: An Interpretable Machine Learning Anomaly Detection Approach for High-Risk Phenotyping in Resected Solid Pseudopapillary Tumors | Claudio Ricci |
| 597 | PSUR-045 | TachoSil® to Prevent Postpancreatectomy Hemorrhage After Distal Pancreatectomy: A Propensity-Weighted Pilot Study | Carlo Ingaldi |
| 600 | PSUR-046 | Variability in the Management of Postoperative Pancreatic Exocrine Insufficiency and Pancreatic Enzyme Replacement Therapy: A European Survey | Giulia Gasparini |
| 608 | PSUR-047 | Delayed Gastric Emptying after Robotic Pancreatoduodenectomy: a retrospective European multicenter analysis | Riccardo Pellegrini |
Beşiktaş Poster Hall / 13.00 – 14.00 |
|||
| *Please kindly note that each presentation is allocated 4 minutes (3-minute presentation + 1-minute discussion) | |||
| AbsRef | Pub Number | Title | Presenter |
| Group – 8 | Chairs: Timothy B. Gardner (Dartmouth, USA), Natalya Guibertis (Odesa, Ukraine) | ||
| 106 | PAPC-001 | Enhanced early prediction of acute pancreatitis severity using a SHAP-driven XGBoost model: advancing beyond conventional scoring systems | María Lourdes Ruiz Rebollo |
| 117 | PAPC-002 | Retrospective analysis of body composition in patients with walled-off pancreatic necrosis at a tertiary centre: a single-centre experience | Lilla Horváth |
| 126 | PAPC-003 | Clinical Outcomes of the Minimally Invasive “Step-up Approach” in Severe Acute Pancreatitis Management | Igor A. Kryvoruchko |
| 127 | PAPC-004 | The role of syndecan-1 in predicting the course of acute pancreatitis: analysis of treatment of 84 patients | Igor A. Kryvoruchko |
| 135 | PAPC-005 | Body composition as a marker of acute pancreatitis severity: a systematic review and meta-analysis | Nina Blazevic |
| 145 | PAPC-006 | Is stress-induced pancreatitis possible? | Natalya Gubergrits |
| 167 | PAPC-007 | SHASTA-5 rationale and design: randomized, double-blind, placebo-controlled study to evaluate plozasiran efficacy for reduction of pancreatitis risk | Peter Hegyi |
| 168 | PAPC-008 | Different spectrum of microorganisms and clinical characteristics in infected necrotizing pancreatitis patients with and without “gas bubbles” | Yixuan Ding |
| 188 | PAPC-009 | The great imitator: necrotizing acute pancreatitis, pancreatic tumor, or extrapulmonary tuberculosis? | Emese Fürst |
| 211 | PAPC-010 | A systematic review of measurement of oxidative stress and clinical implications in acute pancreatitis | Shantata Kudchadkar |
| 220 | PAPC-011 | Progression from acute to chronic pancreatitis in children: A systematic review and meta-analysis | Endre Botond Gagyi |
| 221 | PAPC-012 | Effect of esmolol on organ function in predicted severe acute pancreatitis: a multicenter randomized clinical trial | Lu Ke |
| 230 | PAPC-013 | Type 1 Autoimmune Pancreatitis with Normal Serum IgG4 Levels: a Milder Variant or a Distinct Entity? | Salvatore Crucillà |
| 239 | PAPC-014 | Prediction of long-term post-necrotic pancreatic dysfunction in patients with acute necrotizing pancreatitis | Liudmyla V. Levchenko |
| 241 | PAPC-015 | Correlation between Body Mass Index and Extrapancreatic Destruction in Acute Necrotizing Pancreatitis | Inna O. Kovalska |
| Group – 9 | Chairs: Vinciane Rebours (Paris, France), İlgin Özden (Istanbul, Turkiye) | ||
| 242 | PAPC-016 | The role of primary drainage of the retroperitoneal space in the treatment of intra-abdominal hypertension in acute severe pancreatitis | Ivanna A. Shchyhel |
| 246 | PAPC-017 | Anticoagulant Therapy in Acute Pancreatitis-related Splanchnic Venous Thrombosis – A Retrospective cohort study | Devarajulu Mariyappan |
| 251 | PAPC-018 | Does Timing Matters? ERCP Performed During Acute Versus Post-Acute Pancreatitis: A 25-Year Real-World Comparative Study From Two High-Volume Centers | Theodoros A Voulgaris |
| 259 | PAPC-019 | Short-term outcomes of Arterial Divestment in Pancreatic Cancer: A Systematic Review and Single Arm Meta-analysis of observational studies | Vivek Peddakota |
| 280 | PAPC-020 | Development and validation of an interpretable machine learning model for early prediction of organ failure in acute pancreatitis patients: A multicenter cohort study | Di Wu |
| 303 | PAPC-021 | A higher spontaneous resolution rate of biliary sludge compared with gallstones may trigger a lower cholecystectomy rate after acute biliary pancreatitis | Max Ole Hubert |
| 327 | PAPC-022 | Pancreatic Volume Increase Following GLP-1 Receptor Agonist Therapy: A Real-World CT-Based Cohort Study | Yanna Cai |
| 336 | PAPC-023 | Serial Serum and Urine Proteomic Profiling Identifies Novel Prognostic Biomarkers on Admission for Predicting Severe Acute Pancreatitis | Zihan Yang |
| 348 | PAPC-024 | Necrotizing of Pancreatitis:Five-Year Clinical Experience and Surgical management Strategy at Vivamedi Clinic tbilisi georgia | Zurab Zurab Chkhaidze |
| 353 | PAPC-025 | Diagnostic pitfalls of lipase elevation in active IBD: distinguishing true pancreatitis from inflammatory hyperlipasemia | Motaz Ashkar |
| 386 | PAPC-026 | Serum proteomics profiling identifies Cela3a and CTRC as novel acute pancreatitis diagnostic biomarkers with superior diagnostic performance to lipase | Yonghao Chen |
| 432 | PAPC-027 | Microbiology of infected walled-off pancreas necrosis – a single center retrospective study | Gábor Gieszinger |
| 457 | PAPC-028 | Impact of drugs on the incidence of post-ERCP pancreatitis: the PEP-TALK study | Chiara Coluccio |
| 464 | PAPC-029 | A study of long-term follow-up of patients with recurrent acute pancreatitis | Gauri Kumbhar |
| 476 | PAPC-030 | Comparative efficacy of Chinese herbal injections with blood-activating and stasis-resolving effects for severe acute pancreatitis: a systematic review and network meta-analysis | Yongzi Wu |
| Group – 10 | Chairs: Georg Beyer (Munich, Germany), Sara Nikolic (Maribor, Slovenia) | ||
| 491 | PAPC-031 | IgG4-Related Pancreatobiliary Disease: Clinical Spectrum and Outcomes from a Single-Center Experience | Oussama Trabelsi |
| 500 | PAPC-032 | Outcome selection in randomised controlled trials of drugs for acute pancreatitis | Juan Lin |
| 509 | PAPC-033 | Utility of routine microbiology sampling following Lumen apposing metal stent (LAMs) insertion for walled off necrosis (WON) in patients with Severe necrotising pancreatitis (SAP) | Joshua Michael Clements |
| 512 | PAPC-034 | Delayed cholecystectomy and 90-day recurrence after a first episode of acute biliary pancreatitis | Yavuz Özden |
| 513 | PAPC-035 | Clinical predictors of new-onset diabetes after a first episode of acute pancreatitis | Yavuz Özden |
| 514 | PAPC-036 | Association of Body Composition with Etiology and Disease Course in Acute Pancreatitis: A Prospective Observational Cohort Study of 1,347 Patients | Olga Julia Zahariev |
| 524 | PAPC-037 | Digital Bowel Sound Analysis for Early Severity Prediction in Acute Pancreatitis | Ziying Han |
| 527 | PAPC-038 | Splanchnic and extra-splanchnic venous thrombosis in moderately severe and severe acute pancreatitis: Predictors and outcomes from a prospective study | Vivek Peddakota |
| 537 | PAPC-039 | Safety and Efficacy of ERCP and Cholecystectomy in Pregnant Patients with Biliary Pancreatitis | Dorottya Tarjan |
| 540 | PAPC-040 | Chronic cardiac diseases, acute heart failure and ECG abnormalities are associated with worse outcomes in AP – a multicentre registry-based cohort study | Veronika Lillik |
| 542 | PAPC-041 | Early changes in renal function predict key clinical outcomes in acute pancreatitis: a multicentre registry-based study | Edina Tari |
| 543 | PAPC-042 | Non-invasive Ventilation for Prevention of Intubation in Severe Acute Pancreatitis: A Systematic Review and Meta-analysis | Marcell Kovács |
| 545 | PAPC-043 | Changes in Pancreatic Morphology and Endocrine Function After Acute Pancreatitis: Preliminary Results of the GOULASH Plus Longitudinal Study | Alexandra Mikó |
| 563 | PAPC-044 | Nosocomial infection surveillance in a tertiary pancreatic center: a prospective cohort study | Zoltán Hajnády |
| 582 | PAPC-046 | Perioperative skeletal muscle loss and clinical severity in surgically treated patients with infected necrotizing pancreatitis | Viktoriia Teterina |
| Group – 14 | Chairs: Giuseppe Vanella (Milan, Italy), Gürhan Sisman (Istanbul, Turkiye) | ||
| 85 | PEND-001 | Percutaneous endoscopic necrosectomy as a promising treatment method for difficult collections of walled-off pancreatic necrosis | Agata Chwarscianek |
| 97 | PEND-002 | Improved EUS-FNB needle-tip design limits the number of needle passes and argues the added value of ROSE in patients with Pancreatic Ductal Adenocarcinoma | Mike J.P. de Jong |
| 137 | PEND-003 | From Visualization to Intervention EUS in IgG4-Related Acute Pancreatic Disease | Sofiia Ivina |
| 146 | PEND-004 | Forward-Viewing Echoendoscope–Guided Interventional Therapy for Pancreatic Cystic Lesions | Sofiia Ivina |
| 147 | PEND-005 | Hybrid EUS Interventions in Pancreatic Pseudocysts A Prospective Cohort Study | Sofiia Ivina |
| 169 | PEND-006 | Integrating ERCP within UK Higher Surgical Training: A Structured, Curriculum-Embedded Model | Javed Latif |
| 215 | PEND-007 | EUS-guided tissue acquisition with or without on-site evaluation: a single center experience from the Hungarian Institute of Pancreatic Diseases | Camille Turquier |
| 217 | PEND-008 | A Rare Case: Isolated Pancreatic Metastasis of Renal Cell Carcinoma | Rauf Mehtiyev |
| 219 | PEND-009 | Late Pancreatic Metastasis of Renal Cell Carcinoma | Rauf Mehtiyev |
| 223 | PEND-010 | Gastric Outlet Obstruction as a Rare Clinical Manifestation of Disconnected Pancreatic Duct Syndrome: Success of a Step-Down Conservative Strategy | Livia Zornetta |
| 228 | PEND-011 | The efficacy and safety of endoscopic ultrasound-guided pancreatic drainage for main pancreatic duct obstruction | Sung Hyun Cho |
| 229 | PEND-012 | Diagnostic Accuracy of On-site Evaluation Techniques in Pancreatic Neoplasia Sampling: A Systematic Review and Meta-analysis | Zoltán Imre Bánfalvi |
| 245 | PEND-013 | Retrospective analysis of EUS-guided elastography and Histopathological results in differentiating solid Pancreatic lesions at the Institute of Pancreatic Diseases, Semmelweis University | Devarajulu Mariyappan |
| 252 | PEND-014 | Biliary stricture anatomical characteristics affects the development of post- ERCP pancreatitis | Theodoros A Voulgaris |
| 256 | PEND-015 | Diagnostic utility of pancreatic and bile duct brushing for pancreatic cancer during ERCP: a systematic review and meta-analysis | Gergely Kollányi |
| Group – 15 | Chairs: Lucía Guilabert Sanz (Elche, Spain), Dong-Wan Seo (Soeoul, South Korea) | ||
| 272 | PEND-016 | Igor Khomiak, Petro Ogorodnyk, Andrii Deinychenko, Nataliia Yermak, Ivan Lukecha | Igor Khomiak |
| 287 | PEND-017 | Preliminary experience on the incidence and severity of post-ERCP pancreatitis in distal malignant biliary obstruction: a single tertiary-center analysis | Salvatore Crucillà |
| 294 | PEND-018 | Endoscopic Treatment of Difficult Bile Duct Stones | Igor Khomiak |
| 319 | PEND-019 | Influence of papilla morphology on ERCP cannulation strategies: an international survey | Edina Tari |
| 343 | PEND-020 | Kimura disease of the pancreas mimicking a solid pancreatic neoplasm: Diagnosis by EUS-guided fine-needle aspiration | Charalampos Thanos |
| 359 | PEND-021 | Outcomes of endoscopic biliary drainage in pancreatic head cancer: a single-center experience | Manel Yakoubi |
| 360 | PEND-022 | Predictors of ERCP failure in pancreatic head cancer: experience of a Tunisian center | Manel Yakoubi |
| 361 | PEND-023 | Predictors of post-ERCP complications in pancreatic head cancer: a monocentric tunisian cohort | Manel Yakoubi |
| 437 | PEND-024 | Feasibility of a Modified Intraductal Fully Covered Self-Expandable Metal Stent in Unresectable Malignant Hilar Obstruction | Tae Hoon Lee |
| 441 | PEND-025 | Systemic Triplet-Regimen Chemotherapy could be a Major Contributing Factor to Stent Dysfunction in Patients with Malignant Hilar Obstruction | Chang Il Kwon |
| 442 | PEND-026 | Impact of Fatty Liver and Visceral Fat on Post-ERCP Pancreatitis in patients undergoing ERCP with standard prophylaxis | Krishna P Bharadwaj |
| 467 | PEND-027 | Tiered Management of ERCP-Induced Pancreatic Duct Injuries | Hao Luo |
| 475 | PEND-028 | Percutaneous endoscopic necrosectomy: integrating a new modality into a step-up treatment approach for infected necrotizing pancreatitis | Gabriel Alexander Salg |
| 556 | PEND-030 | Clinical relevance of biliary sampling and the impact of stent biofilms: a retrospective analysis from a tertiary referral centre | Emese Rita Fürst |
| 579 | PEND-031 | Odesa Criteria 2026 (OC26): A novel diagnostic algorithm for AIP using SPEP and EUS Doppler | Sofiia Ivina |
